Ichor Holdings Reports Q1 2026 Results with Improved Net Loss and Non-GAAP EPS, but Operating Cash Flow Turns Negative
ICHR has more than doubled off its 52-week low of $13.12 on elevated volume (2.6× avg).
Summary
Ichor Holdings reported improved Q1 2026 GAAP net loss and increased Non-GAAP EPS, but operating cash flow turned negative, and key executives established 10b5-1 selling plans.
Key Events · Earnings and Guidance · ICHR
-
Q1 2026 Financial Performance
Net sales increased to $256.1 million, GAAP net loss narrowed to $(2.5) million from $(4.6) million in Q1 2025, and Non-GAAP diluted EPS rose to $0.15 from $0.12 in Q1 2025.
-
Operating Cash Flow Turns Negative
The company reported negative cash flow from operating activities of $(2.9) million in Q1 2026, a significant decrease from the positive $19.0 million generated in Q1 2025.
-
Ongoing Restructuring Plan
The consolidation restructuring plan incurred $0.5 million in costs during Q1 2026, with an additional $2.2 million in fixed asset charges and $0.9 million in operating lease ROU asset impairment charges still expected.
-
Singapore Tax Holiday Ends
The tax holiday in Singapore concluded on March 31, 2026, contributing to an increase in income tax expense and a higher effective tax rate for the quarter.
Analysis · ICHR · Manufacturing
This 10-Q filing provides the full financial details for Q1 2026, following the preliminary earnings release via an 8-K on May 4, 2026. While the company reported improved GAAP net loss and increased Non-GAAP net income and diluted EPS, driven by higher net sales and gross margin, a significant concern arises from the shift to negative operating cash flow. The company used $2.9 million in operating activities during the quarter, a notable reversal from the $19.0 million provided in the prior year. Additionally, the filing details ongoing restructuring costs and the expiration of a tax holiday in Singapore, which will impact future tax expenses. The disclosure of Rule 10b5-1 trading plans by the CEO and CFO for potential future share sales, while pre-planned, adds a layer of potential selling pressure.
At the time of this filing, ICHR was trading at $63.15 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $13.12 to $72.87. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.